In a notable development for D2C news India and the broader D2C ecosystem India, Ahmedabad-based RehabVeda made a strong impact on Shark Tank India Season 5, securing fresh capital to scale its neurorehabilitation technology platform. For those tracking D2C daily news, D2C startup news, and Indian D2C updates, RehabVeda’s funding milestone signals how deep-tech healthcare startups are increasingly becoming part of the evolving Direct-to-consumer India growth narrative.
Founded in 2019 by Shyam Parmar and Neel Patel, RehabVeda is transforming neurorehabilitation through advanced brain-computer interface systems that integrate EEG-based neurofeedback, assistive robotics, and digital therapeutics. Designed to accelerate motor recovery for stroke and paralysis patients, the platform is built for both clinical settings and home use, offering scalable, data-driven, and personalized therapy solutions. As D2C industry news continues to spotlight D2C wellness startups and digital health innovation, RehabVeda stands at the intersection of healthtech, AI-driven therapy, and patient-centric design.
On Shark Tank India Season 5, the founders sought ₹1 crore for 2.5% equity, implying a D2C startup valuation of ₹40 crore. After negotiations, Sharks Namita Thapar and Mohit Yadav made a counter-offer of ₹1 crore for 3% equity. The founders accepted the offer, securing angel investment D2C capital that strengthens RehabVeda’s ability to accelerate product development, expand distribution, and scale its clinical partnerships across India.
RehabVeda’s model aligns closely with emerging D2C market trends 2025, where technology-enabled healthcare and digital therapeutics are gaining traction. While much of the D2C funding news focuses on D2C beauty and skincare India, D2C personal care brands, and Premium D2C brands India, platforms like RehabVeda highlight how D2C business India is expanding into high-impact, science-driven categories. Its hybrid model—serving hospitals while enabling home-based therapy—reflects a strong Omnichannel D2C strategy tailored to healthcare delivery.
The company’s brain-computer interface system leverages EEG signals to provide real-time neurofeedback, helping patients retrain neural pathways. By integrating assistive robotics and digital therapeutics, RehabVeda enhances recovery outcomes while enabling personalized treatment plans. This technology-first approach aligns with D2C supply chain innovation and D2C go-to-market strategy trends that prioritize measurable outcomes and user-centric design.
In the broader context of VC-backed D2C brands and Series A/B/C funding India narratives, early-stage deals like RehabVeda’s demonstrate investor confidence in category-defining innovation. As discussions around D2C expansion plans, D2C product launches, and D2C revenue growth intensify, healthtech startups are becoming an important pillar of the D2C ecosystem India.
For stakeholders asking what’s happening in India’s D2C space today, RehabVeda’s Shark Tank deal underscores the rise of technology-driven wellness platforms within Latest D2C startups. With increasing investor interest, Private equity in D2C, and structured growth roadmaps, such ventures are contributing to India’s D2C market news and insights landscape.
As India moves toward a more tech-enabled healthcare infrastructure, RehabVeda’s funding milestone reinforces its ambition to scale advanced neurorehabilitation solutions nationally. By combining clinical-grade innovation with scalable digital delivery, the startup strengthens its position within Direct-to-consumer India—adding momentum to the next wave of D2C brands scaling in 2025.
